Subscribe to RSS
DOI: 10.1055/s-2008-1072507
Regio- and Chemoselective Unprecedented Imino-Diels-Alder Reactions of 1-Substituted Unactivated Dienes with N-Aryl Imines - Part II [1]
Publication History
Publication Date:
17 March 2008 (online)
Abstract
The chemo- as well as regioselective participation of N-aryl imines as 4π component in aza-Diels-Alder reactions with 3-butadienyl-2-azetidinones in the presence of Lewis acid catalysts resulting in novel quinoline derivatives is described.
Key words
dienyl-2-Azetidinones - imino-Diels-Alder reactions - Lewis acid - regioselectivity - chemoselectivity - quinoline derivatives
- 1
Bhargava G.Kumar V.Mahajan MP. Tetrahedron Lett. 2007, 48: 2365 - For leading references, see:
-
2a
Daly JW.Spande TF. Alkaloids: Chemical and Biological Perspectives Vol. 4:Pelletier SW. Wiley; New York: 1986. p.1-254 -
2b
Fodor GB.Colasanti B. Alkaloids: Chemical and Biological Perspectives Vol. 3:Pelletier SW. Wiley; New York: 1985. p.1-91 -
2c
Boger D.Weinreb SM. Hetero Diels-Alder Methodology in Organic Synthesis Academic; San Diego: 1987. Chap. 2. p.34-70 -
2d
Boger D.Weinreb SM. Hetero Diels-Alder Methodology in Organic Synthesis Academic; San Diego: 1987. Chap 9. p.239-299 ; and references therein -
2e
Boger DL.Patel M. In Progress in Heterocyclic ChemistrySuschitzky H.Scriven EFV. Pergamon; New York: 1989. p.1-30 -
2f
Kametani T.Hibino S. Adv. Heterocycl. Chem. 1987, 42: 246 -
3a
Tietze LF.Kettschau G. Top. Curr. Chem. 1997, 189: 1 -
3b
Kobayashi S. Eur. J. Org. Chem. 1999, 15 -
3c
Panunzio M.Zarantonello P. Org. Process Res. Dev. 1988, 2: 49 -
3d
Enders D.Meyer O. Liebigs Ann. 1996, 1023 -
3e
Waldmann H. In Organic Synthesis Highlights IIWaldman H. VCH; New York: 1995. p.37-47 -
3f
Waldmann H. Synthesis 1994, 535 -
3g
Waldmann H.Braun M. Gazz. Chim. Ital. 1991, 121: 277 -
3h
Waldmann H. Synlett 1995, 133 -
3i
Barluenga J.Joglar J.Gonzalez FJ.Fustero S. Synlett 1990, 129 -
3j
Parker DT. In Organic Synthesis in WaterGrieco PA. Blacky Academic and Professional; London: 1998. -
3k
Barluenga J.Tomas M. Adv. Heterocycl. Chem. 1993, 57: 1 - For selected examples, see:
-
4a
Hermitage S.Howard JAK.Jay D.Pritchard RG.Probert MR.Whiting A. Org. Biomol. Chem. 2004, 2: 2451 -
4b
Badorrey R.Cativiela C.Dfaz-de-Villegas MD.Galvez JA. Tetrahedron 1999, 55: 7601 - 5
Garcia A.-B.Valdes C.Cabal M.-P. Tetrahedron Lett. 2004, 45: 4357 - For recent reviews, see:
-
6a
Buonora P.Olsen J.-C.Oh T. Tetrahedron 2001, 57: 6099 -
6b
Jørgensen KA. Angew. Chem. Int. Ed. 2000, 39: 3558 ; and references cited therein -
6c
Orr RK.Calter MA. Tetrahedron 2003, 59: 3545 ; and references cited therein -
7a
Kobayashi S.Nagayama S. J. Am. Chem. Soc. 1996, 118: 8977 -
7b
Kobayashi S.Ishitani H.Nagayama S. Chem Lett. 1995, 24: 423 -
7c
Kobayashi S.Ishitani H.Nagayama S. Chem. Lett. 1995, 24: 423 -
7d
Ishitani H.Kobayashi S. Tetrahedron Lett. 1996, 37: 7357 -
7e
Kobayashi S.Araki M.Ishitani H.Nagayama S.Hachiya I. Synlett 1995, 233 -
7f
Kobayashi S.Ishitani H.Nagayama S. Synthesis 1995, 1195 - 8
Sharma AK.Mazumdar SN.Mahajan MP. J. Org. Chem. 1996, 61: 5506 -
9a
Goel RK.Kumar V.Mahajan MP. Bioorg. Med. Chem. Lett. 2005, 15: 2145 -
9b
Bedi PMS.Kumar V.Mahajan MP. Bioorg. Med. Chem. Lett. 2004, 14: 5211 -
9c
Goel RK.Thind JS.Bal CS.Mahajan MP.Kulkarni SK. Pharmazie 2005, 60: 369 -
9d
Bhargava G.Mahajan MP.Saito T.Otani T.Kurashima M.Sakai K. Eur. J. Org. Chem. 2005, 2397 - For reviews on this subject, see:
-
10a
Southgate R. Contemp. Org. Synth. 1994, 1: 417 -
10b
Southgate R.Branch C.Coulton S.Hunt E. In Recent Progress in the Chemical Synthesis of Antibiotics and Related Microbial Products Vol. 2:Lukacs G. Springer; Berlin: 1993. p.621 -
10c
Ojima I. The Organic Chemistry of β-LactamsGeorg GI. VCH; New York: 1993. p.197 -
10d
The Chemistry of β-Lactams
Page MI. Chapman and Hall; London: 1992. -
10e
Southgate R.Elson S. In Progress in the Chemistry of Organic Natural Products Vol. 47:Herz W.Grisebach H.Kirby GW.Tamm C. Springer; Vienna: 1985. p.1 - For reviews, see:
-
11a
Mascaretti OA.Boschetti CE.Danelon GO.Mata EG.Roveri OA. Curr. Med. Chem. 1995, 1: 441 -
11b
Edwards PD.Bernstein PR. Med. Res. Rev. 1994, 14: 127 -
12a
Vaccaro WD.Davis HR. Bioorg. Med. Chem. Lett. 1998, 8: 313 -
12b
Vaccaro WD.Sher R.Davis HR. Bioorg. Med. Chem. Lett. 1998, 8: 35 -
12c
Burnett DA. Tetrahedron Lett. 1994, 35: 7339 -
13a
Borthwick AD.Weingarten G.Haley TM.Tomaszewski M.Wang W.Hu Z.Bedard J.Jin H.Yuen L.Mansour TS. Bioorg. Med. Chem. Lett. 1998, 8: 365 -
13b
Ogilvie W.Bailey M.Poupart M.-A.Abraham A.Bhavsar P.Bonneau P.Bordeleau J.Bousquet Y.Chabot C.Duceppe J.-S.Fazal G.Goulet S.Grand-Maitre C.Guse I.Halmos T.Lavallee P.Leach M.Malefant E.O’Meara J.Plante R.Plouffe C.Poirier M.Soucy F.Yoakim C.Deziel R. J. Med. Chem. 1997, 40: 4113 - 14
Han WT.Trehan AK.Wright JJK.Federici ME.Seiler SM.Meanwell NA. Bioorg. Med. Chem. 1995, 3: 1123
References and Notes
3-[2-(6-Methoxy-2-phenyl-quinolin-4-yl)-vinyl]-1,4-diphenyl-azetidin-2-one (4a): white solid, mp 170-171 °C. 1H NMR (600 MHz, CDCl3): δ = 3.90 (s, 3 H, OCH3), 4.12 (dd, J = 2.3, 7.6 Hz, 1 H, H3), 4.90 (d, J = 2.3 Hz, 1 H, H4), 6.71 (dd, J = 7.6, 15.5 Hz, 1 H, H5), 7.10 (t, J = 6.8 Hz, 1 H, arom.), 7.41 (m, 13 H, arom. and H12), 7.50 (d, J = 15.5 Hz, 1 H, H6), 7.52 (s, 1 H, H14), 7.90 (s 1 H, H8), 8.08 (d, J = 9.2 Hz, 1 H, H11) 8.13 (d, J = 7.4 Hz, 2 H, H18). 13C NMR (75 MHz, CDCl3): δ = 53.4, 61.6, 63.8, 101.4, 115.9, 117.1, 122.0, 124.2, 125.9, 127.2, 128.0, 128.5, 128.7, 128.8, 128.9, 129.1, 129.3, 130.3, 131.7, 137.0, 137.4, 139.7, 141.2, 144.7, 154.8, 157.8, 164.7. MS: m/z = 482 [M]+. IR (KBr): νmax = 1752, 1627, 1565, 1508, 1387 cm-1. Anal. Calcd for C33H26N2O2: C, 82.13; H, 5.43; N, 5.81. Found: C, 82.27; H, 5.58; N, 5.66.